- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Acumen Pharmaceuticals Inc (ABOS)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.135
3.340
52 wk Range
1.210
3.600
Acumen Pharmaceuticals (ABOS) Technical Analysis
Assess Acumen Pharmaceuticals (ABOS) technical analysis based on moving-average signals and common indicators such as RSI, MACD and CCI, ranging from strong buy to strong sell. Review the ABOS signals across a customisable timeframe to decide whether the stock is a buy or sell for your personal share portfolio.
Summary:Buy
| Moving Averages: | Buy | Buy: (8) | Sell: (4) |
| Technical Indicators: | Buy | Buy: (5) | Sell: (3) |
Technical Indicators
Summary: BuyBuy: 4Neutral: 3Sell: 3
Aug 21, 2026 21:07 GMT
Name | Value | Action | ||
|---|---|---|---|---|
| RSI(14) | 62.429 | Buy | ||
| STOCH(9,6) | 43.888 | Sell | ||
| STOCHRSI(14) | 0 | Oversold | ||
| MACD(12,26) | 0.114 | Buy | ||
| ADX(14) | 55.498 | Sell | ||
| Williams %R | -54.201 | Neutral | ||
| CCI(14) | 3.2375 | Neutral | ||
| ATR(14) | 0.0778 | Less Volatility | ||
| Highs/Lows(14) | 0 | Neutral | ||
| Ultimate Oscillator | 47.303 | Sell | ||
| ROC | 0.317 | Buy | ||
| Bull/Bear Power(13) | 0.047 | Buy | ||
Moving Averages
Summary: BuyBuy: 8Sell: 4
Aug 21, 2026 21:07 GMT
Name | Simple | Exponential | |||
|---|---|---|---|---|---|
| MA5 | 3.199 Sell | | 3.183 Sell | | |
| MA10 | 3.194 Sell | | 3.174 Sell | | |
| MA20 | 3.123 Buy | | 3.095 Buy | | |
| MA50 | 2.817 Buy | | 2.878 Buy | | |
| MA100 | 2.581 Buy | | 2.678 Buy | | |
| MA200 | 2.394 Buy | | 2.528 Buy | | |
Pivot Points
Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 3.13 | 3.145 | 3.165 | 3.18 | 3.2 | 3.215 | 3.235 |
| Fibonacci | 3.145 | 3.158 | 3.167 | 3.18 | 3.193 | 3.202 | 3.215 |
| Camarilla | 3.175 | 3.179 | 3.182 | 3.18 | 3.188 | 3.191 | 3.195 |
| Woodie's | 3.132 | 3.146 | 3.167 | 3.181 | 3.202 | 3.216 | 3.237 |
| DeMark's | - | - | 3.173 | 3.184 | 3.207 | - | - |
FAQ
Is Acumen Pharmaceuticals (ABOS) a Buy or Sell, from a Technical Analysis Perspective?
Based on moving averages and other technical indicators, today's Acumen Pharmaceuticals buy/sell signal is Strong Buy.
What Do The Current Moving Averages for Acumen Pharmaceuticals (ABOS) Show?
The moving averages for Acumen Pharmaceuticals show a Strong Buy outlook, considering moving averages ranging from MA5 to MA200, with 12 Buy signals and 0 Sell signals.
What Do Today's Technical Indicators for Acumen Pharmaceuticals Show?
The technical indicators for Acumen Pharmaceuticals are in a Strong Buy position based on daily analysis, with 6 signals on buy indicators and 0 sell signals.
What Is Acumen Pharmaceuticals (ABOS)'s 14-Day RSI?
The current Relative Strength Index (RSI) of ABOS over the 14-day period is 62.429, which suggests that the stock is a Buy.
What Is Acumen Pharmaceuticals (ABOS)'s MACD?
ABOS's MACD (Moving Average Convergence/Divergence) is 0.114, which suggests that the stock is a Buy.
What Is Acumen Pharmaceuticals (ABOS)'s 5-Day Moving Average?
ABOS's 5-day moving average is 3.199, suggesting that the stock is a Sell.
What Is Acumen Pharmaceuticals (ABOS)'s 50-Day Moving Average?
ABOS's 50-day moving average is 2.817, suggesting that the stock is a Buy.
What Is Acumen Pharmaceuticals (ABOS)'s 200-Day Moving Average?
ABOS's 200-day moving average is 2.394, suggesting that the stock is a Buy.
What Is the Fibonacci Pivot Point Performance Value for Acumen Pharmaceuticals (ABOS)?
The Fibonacci pivot point performance value for ABOS is 3.180.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.